Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease
We address an unmet challenge in Parkinson's disease: the lack of biomarkers to identify
the right patients for the right therapy, which is a main reason clinical trials for disease …
the right patients for the right therapy, which is a main reason clinical trials for disease …
Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease
H Payami, TR Sampson, CF Murchison - 2024 - europepmc.org
We address an unmet challenge in Parkinson's disease: the lack of biomarkers to identify
the right patients for the right therapy, which is a main reason clinical trials for disease …
the right patients for the right therapy, which is a main reason clinical trials for disease …